Trialbee announces the release of HIVE™, a smart data science application applied on real-world data (RWD) to enhance targeting and precision in performance-driven patient recruitment for global clinical trials.
See what we are up to and where you can meet with us at upcoming events around the globe
Trialbee announces the release of HIVE™, a smart data science application applied on real-world data (RWD) to enhance targeting and precision in performance-driven patient recruitment for global clinical trials.
For it’s COVID vaccine study, Moderna leveraged TrialScope Connect, an industry-first participant referral collective that connects sponsors and recruitment partners to rapidly find, screen and enroll clinical trial participants, during the final enrollment period.
To address common challenges with clinical trial recruitment, Trialbee has partnered with LiveRamp, the leading data connectivity platform, to find a pool of potential trial participants and then engage them for clinical trials in a patient-centric way.
Trialbee announced a partnership with LiveRamp to leverage LiveRamp’s Identity Infrastructure and network of data providers to identify and reach potential clinical trial participants and remain engaged with those participants throughout their clinical trial journey.
We discuss the Food and Drug Administration guidance about enhancing diversity in clinical trials: “Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs,” which was issued last week.
The timeline for vaccine development is lengthy and during a pandemic, resolution of the disease before a vaccine is approved can put development on hold indefinitely. Participant recruitment and engagement can help shorten the timelines.
Trialbee is pleased to announce that we are providing patient recruitment services to promote patient diversity for vaccine trials investigating the safety and efficacy of leading vaccine candidates against COVID-19 and funded by BARDA, part of the HHS Office of the Assistant Secretary for Preparedness and Response.
To address patient attrition, sponsors and CROs must employ patient-centric solutions to help keep patients engaged and informed throughout the trial. In this blog post, we’ll cover ways to prevent attrition and improve communication with patients.
The diversity in clinical trials needs to reflect the diversity in the target population. Only then can we determine the safety and efficacy of drugs and medical products across all ages, races, ethnic groups, and genders that could benefit from the drug or product. However, diversity is hard to achieve and requires both strategic know-how and expert execution to deliver.
Trialbee is pleased to announce our partnership with Clinerion to accelerate time to market by shortening patient recruitment and enrollment timelines and reduce costs associated with patient recruitment and loss-to-follow-up.
Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?